Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study

OBJECTIVE: Midodrine hydrochloride is a short-acting pressor agent that raises blood pressure in the upright position in patients with orthostatic hypotension. The US Food and Drug Administration’s Subpart H approval, under which midodrine was initially approved, requires post-marketing studies to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, William, Wan, Hong, Much, David, Robinson, Antoine G., Martin, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951503/
https://www.ncbi.nlm.nih.gov/pubmed/27372462
http://dx.doi.org/10.1007/s10286-016-0363-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951503/
https://www.ncbi.nlm.nih.gov/pubmed/27372462
http://dx.doi.org/10.1007/s10286-016-0363-9

Ejemplares similares